ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 204 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $252,000 | -47.3% | 13,505 | -57.3% | 0.00% | -100.0% |
| Q1 2021 | $478,000 | +392.8% | 31,600 | +163.3% | 0.00% | – |
| Q3 2020 | $97,000 | +34.7% | 12,000 | +8.1% | 0.00% | – |
| Q2 2020 | $72,000 | -48.2% | 11,100 | -21.3% | 0.00% | – |
| Q4 2019 | $139,000 | -13.1% | 14,100 | -6.0% | 0.00% | – |
| Q3 2019 | $160,000 | -9.6% | 15,000 | -19.8% | 0.00% | -100.0% |
| Q4 2018 | $177,000 | +7.9% | 18,700 | +62.6% | 0.00% | – |
| Q3 2018 | $164,000 | -14.6% | 11,500 | -14.8% | 0.00% | -100.0% |
| Q3 2017 | $192,000 | -83.2% | 13,500 | -84.9% | 0.00% | -80.0% |
| Q2 2017 | $1,145,000 | +174.6% | 89,359 | +171.6% | 0.01% | +150.0% |
| Q1 2017 | $417,000 | +18.5% | 32,900 | -4.6% | 0.00% | 0.0% |
| Q4 2016 | $352,000 | +44.9% | 34,500 | +83.5% | 0.00% | +100.0% |
| Q3 2016 | $243,000 | -26.8% | 18,800 | -29.3% | 0.00% | -50.0% |
| Q2 2016 | $332,000 | – | 26,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,500,000 | $21,593,000 | 4.50% |
| KESTREL INVESTMENT MANAGEMENT CORP | 445,500 | $6,433,000 | 3.14% |
| Adirondack Research & Management Inc. | 155,088 | $2,239,000 | 3.06% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 9,398,617 | $135,716,029,000 | 2.92% |
| Waterfront Wealth Inc. | 136,976 | $1,978,000 | 1.40% |
| Smith, Graham & Co., Investment Advisors, LP | 1,008,283 | $14,560,000 | 1.34% |
| S&T BANK/PA | 475,184 | $6,862,000 | 1.23% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,132,500 | $16,354,000 | 0.98% |
| HENNESSY ADVISORS INC | 1,024,100 | $14,788,000 | 0.95% |
| BEACONLIGHT CAPITAL, LLC | 208,546 | $3,011,000 | 0.91% |